Status: Recruiting
Prospective National Cohort Evaluating Prognostic Factors for Efficacy of Fruquintinib Treatment in Patients With Metastatic Colorectal Cancer
The main objective of this study is to identify the prognostic factors (clinico-biological) for the efficacy (overall survival) of fruquintinib in patients with metastatic colorectal cancer.
Participants needed: 300
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Federation Francophone de Cancerologie DigestiveUpdated: May 26, 2026Locations: 83
Eligibility criteria
Patients aged 18 and over. [+3]
Patient with another concurrent cancer at the time of diagnosis, requiring syste... [+3]